Actively Recruiting
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets
Led by Wael Elbanna Clinic · Updated on 2022-03-04
162
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
For gynecologists, reaching a conclusion about the efficacy of intramyometrial Terlipressin injection versus intramyometrial Carbetocin injection on hemoglobin level and decreasing blood loss in women undergoing open myomectomy that would influence the clinical decision and best practice. Besides enriching the clinical evidence in open myomectomy without using haemostatic tourniquets. For society, our conclusion and recommendation shall maximize the benefits and managing the benefits of the technique used. Moreover, providing more information for women undergoing open myomectomy without using haemostatic tourniquets.
CONDITIONS
Official Title
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 16 to 45 years
- Suitable medical condition for open surgery
- Largest myoma size between 4 cm and 20 cm
- Baseline hemoglobin level of at least 9 g/dl
- No contraindications to glyopressin or carbetocin use
- Presence of myoma-related symptoms such as pelvic pressure, pain, heavy bleeding, or infertility
- Not pregnant at the time of screening (confirmed by negative urine pregnancy test or recent menstrual period within 4 weeks)
You will not qualify if you...
- Use of mechanical tourniquet during open myomectomy
- Previous myomectomy surgery
- History of bleeding disorders
- Current anticoagulation treatment
- History of uncontrolled ischemic heart disease
- Presence of pelvic abnormalities requiring additional surgery
- Treatment with GnRH agonist or ulipristal acetate within 3 months before surgery
- Unable to understand or provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Wael El Banna Clinic
Maadi, Egypt
Actively Recruiting
Research Team
W
Wael El Banna
CONTACT
E
Esraa mohammad
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here